Innovative Antibody Drug Nanoparticles For Targeted Cancer Drug Delivery

• Unité de recherche: INNOSUISSE
• Numéro de projet: 140.485 INNO-LS
• Titre du projet anglais: Innovative Antibody Drug Nanoparticles For Targeted Cancer Drug Delivery

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Antibody Drug Conjugates have demonstrated clinical value for hematological tumors and some solid tumors. However challenges remain for many solid tumors. The project will evaluate the generation and potential on a new class of antibody drug nanoparticles for targeted delivery into solid tumors.